CytoMed Therapeutics Ltd

NASDAQ:GDTC 3:59:40 PM EDT

3.41

-0.19 (-5.28%)

Market Cap (Intraday)	37.30M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$0.13 Million
Adjusted EPS	-$0.06

See more estimates

10-Day MA	$3.57
50-Day MA	$3.80
200-Day MA	N/A

See more pivots

CytoMed Therapeutics Ltd Stock, NASDAQ:GDTC

1 Commonwealth Lane, No. 08-22, One Commonwealth, Singapore, Central Singapore 149544

Singapore

Phone: +65.6250.7738

Number of Employees: 28

http://www.cytomed.sg

Description

CytoMed Therapeutics Ltd. operates as a biopharmaceutical company. It engages in the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy. The company was founded by Chee Kong Choo on March 9, 2018 and is headquartered in Singapore.